NCT02956135 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bere T, Alonso JM, Wangensteen A, Bakken A, Eirale C, Dijkstra HP, Ahmed H, Bahr R, Popovic N
Injury and illness surveillance during the 24th Men's Handball World Championship 2015 in Qatar. Br J Sports Med. 2015 Sep;49(17):1151-6. doi: 10.1136/bjsports-2015-094972.
Comerford MJ, Mottram SL
Movement and stability dysfunction--contemporary developments. Man Ther. 2001 Feb;6(1):15-26. Review.
Danis CG, Krebs DE, Gill-Body KM, Sahrmann S
Relationship between standing posture and stability. Phys Ther. 1998 May;78(5):502-17.
Karcher C, Buchheit M
On-court demands of elite handball, with special reference to playing positions. Sports Med. 2014 Jun;44(6):797-814. doi: 10.1007/s40279-014-0164-z. Review.
Michalsik LB, Aagaard P, Madsen K
Locomotion characteristics and match-induced impairments in physical performance in male elite team handball players. Int J Sports Med. 2013 Jul;34(7):590-9. doi: 10.1055/s-0032-1329989.
Van Dillen LR, Sahrmann SA, Norton BJ, Caldwell CA, Fleming DA, McDonnell MK, Woolsey NB
Reliability of physical examination items used for classification of patients with low back pain. Phys Ther. 1998 Sep;78(9):979-88.

Relationship Between Dysfunctions of Movement in the Lower Back and Pelvis With Overuse Injuries in Handball Players

Clinical trial NCT02956135 - References